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While the concept of PCMHs is only in 
its infancy ... the fundamentals have the 
potential to improve health care 
practice and ultimately the health of 
patients nationwide. 
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Introduction 
Health care is a dynamic system and is always progressing in ways that are aimed to improve the health status of patients.1 While 
health care professionals are often reluctant to embrace new operations impacting their daily business, the possibility for over-
whelming benefit in the care of their patients is often enough motivation for providers to accept these changes. 1 The American 
Academy of Pediatrics first described a "medical home" in 1967, which was based upon the notion of "comprehensive care for 
every patient."2 The concept of a patient-centered medical home (PCMH) started to gain steam nearly a decade ago in the early 
2000s, still predominantly within the context of treating children with chronic conditions. 1 Today, the term medical home is de-
fined as an "approach for providing comprehensive and coordinated primary care." 3 The boundaries of PCMHs have expanded 
within recent years. In 2007 the American Academy of Pediatrics, American Academy of Family Practice, American College of Physi-
cians and American Osteopathic Association published a statement that included a summary of the vital components that charac-
terize a PCMH. Furthermore, these organizations called for "accessible, continuous, team-based care that focuses on the whole 
person, with the PCMH taking responsibility for care coordination ." This definition includes improving clinical outcomes as well as 
the overall patient experience.1 
Progression of PCMHs 
Patient-centered medical homes are 
currently thought to have the power to 
improve health outcomes for patients as 
well as potentially reduce overall costs. 
Currently, PCMHs are seen by many as a revolution in health 
care. So, what exactly is a PCMH and how would it affect cur-
rent health care providers? Patient-centered medical homes 
are currently thought to have the power to improve health 
outcomes for patients as well as potentially reduce overall 
costs. Without both of these components, the concept of a 
PCMH would not reach a prominent reality. 1 The National 
Committee for Quality Assurance (NCQA) is considered the 
primary organization responsible for creating PCMH stan- =========-----======-------=====-~ 
dards.4 The first set of standards, created in 2008 and later revised in 2011, placed a large emphasis on patient involvement. 4 Cross-
ing the Quality Chasm, a report created by the Institute of Medicine, put forth "10 Simple Rules for the 21st Century Health Care 
System" to guide the restructuring of the health care system. 5 This report has been a significant building block for the development 
of the NCQA's PCMH guidelines. The report describes a system different from that in existence today and offers suggestions for 
improved health care. A few of the proposed changes include anticipating patient needs rather than reacting to events, allowing 
the patient to be the source of control by providing them with the necessary information to make treatment decisions, sharing 
knowledge freely with the patient and increasing cooperation among clinicians. The fundamental elements of a PCMH according to 
the NCQA include an increased access and continuity to medical care, which involves access to electronic documents as well as the 
ability of a patient to select a clinician and for the patient's health to be based on a team approach. 5 Next, a PCMH must recognize 
and manage the patient population in general by retrieving demographic and clinical data, determining risk factors and instituting 
proactive measures to combat negative health trends.4 Additionally, managed care, which involves pre-appointment planning, cre-
ating patient goals, identifying obstacles to achieving the goals, medication action plans during visits and the use of e-prescribing, is 
deemed to be necessary.4 Similarly, counseling should be provided to enable patients to make healthy choices. This notion of self-
care by patients can be a vital role for pharmacists within PCMHs, especially those in the community and ambulatory setting. 4 Edu-
cating patients about healthy choices may also stimulate patient investment and involvement in their own health care. Coordina-
tion among health care providers is necessary, especially during transitions in care, such as when a patient is discharged from the 
hospital. Patient assessment and feedback of the health care process is also a vital piece of the puzzle. Other required factors in-
clude accessibility of health care professionals during office hours, using the data collected for the management of patient popula-
tions, care management, a patient self-care program, tracking of referrals, following up appointments and a quality improvement 
program. The increased access to care is a calling for pharmacists, due to the fact that pharmacists are one of the most readily ac-
cessible health care professionals.4 
PCMHs and the Current Health care System 
The medical home model requires allocating time and resources up front to the health care reconfigurations that are needed to 
improve care across the health care delivery continuum. 2 However, the current care process for many physicians today can be de-
scribed as "uncoordinated, episodic care." With the introduction of PCMHs, the health care process is now shifting toward 
"comprehensive, integrated, coordinated care that is structured to keep patients out of the hospital." As described by Dr. Paul 
Grundy, President of the Patient-Centered Primary Care Collaborative, "If you manage chronic disease better, fewer beds will be 
needed for people who are being treated as outpatients." According to this thought process, by spending more money up front, 
patient health will take leaps forward; in addition, a significant amount of money can potentially be saved in the long run on costs 
such as hospitalizations for acute events. 2 Similarly, the American College of Physicians (ACP) stated the necessity of the role of 
pharmacists in today's health care system, noting that the rising health care costs are a sign for the need for change. 4 Pharmacists 
already play a vital role in ensuring that patients use their prescribed medication in the correct manner with numerous chronic 
diseases, while also monitoring for adverse events or compliance issues. It has been well documented in the Asheville Project and 
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the Minnesota Medicaid experience that pharmacists can have a positive impact in patient health, as well as being financially bene-
ficial.4 
The Role of Pharmacists in PCMHs 
Pharmacists can have a major impact on the success of PCMHs. A pharmacist working as a part of the PCMH can increase the qual-
ity of patient care, resulting in improved patient health outcomes, especially through monitoring of chronic disease conditions. 3 
Numerous pharmacy health care organizations are stressing the importance of the pharmacists' involvement in PCMHs, especially 
through the clinical service of medication therapy management (MTM), which has been shown to increase patient compliance and 
understanding of medications and lead to improved health outcomes. 4 This is significant since it is estimated that 71 percent of 
adults in the United States have two or more chronic disease states. Additionally, 48 percent of adults in the United States were 
taking four or more prescriptions to manage chronic disease states, which tend to lend itself to the role of a pharmacist in the man-
agement of medication plans. 3 This situation is often demonstrated when pharmacists manage the care of individuals with chronic 
disease states, as long as a new disease is not suspected. For example, a pharmacist can monitor a patient with diabetes and be 
responsible for the transition from oral medications to insulin. This relationship can replace the need for the physician to refer the 
patient to a specialist. A physician and a pharmacist can create a scope of practice outlining what the pharmacist is authorized to 
do, such as when a pharmacist is able to initiate, modify or continue drug therapy in certain patient populations, most notably pa-
tients with chronic disease states. 3 The Affordable Care 
Act, passed in 2010, reiterated the importance of pharma-
cists when it stated in section 3505 that grants from the 
Agency for Healthcare Research and Quality (AHRQ) can be 
provided to "implement medication management services 
provided by licensed pharmacists, as a part of a collabora-
tive, interprofessional approach to the treatment of 
chronic diseases for targeted individuals, to improve the 
quality of care and reduce overall cost in the treatment of 
such diseases." Pharmacists also play a critically important 
role of decreasing the number of medication errors by pro-
viding MTM services.4 
... 48 percent of adults in the United States 
were taking four or more prescriptions 
to manage chronic disease states, which 
tends to lend itself to the role of a 
pharmacist in the management of 
medication plans. 
Similarly, pharmacists can incorporate a large portion of the PCM H's goal of continuity of care into their practice setting. MTM ser-
vices can be provided to patients between their appointments with their primary care physician. This can be especially true for 
patients with a complex medication regimen consisting of a high number of medications, or treatments where progress should be 
monitored for dosage adjustments. 3 It is estimated that only 33 to 50 percent of patients with a chronic condition fully adhere to 
their medication regimen, which demonstrates vast room for improvement and a spot for MTM in health care. 6 Medication ther-
apy management often involves a review of all current medications, including vitamins, herbals and over-the-counter (OTC) prod-
ucts in order to ensure proper use, adherence and safety. These sorts of reviews often resolve errors in therapy, such as 
"inappropriate medication selection, omissions, duplications, subtherapeutic or excessive dosages, drug interactions, adverse 
events, adherence problems" and expensive regimens. 6 These services can be offered by pharmacists in a number of different set-
tings, including physician offices, outpatient clinics, senior centers, community pharmacies and within the patient's own home.3 
Additionally, pre-visit planning by a pharmacist in the medical model can allow recommendations on medication regimens to be 
shared with the physician.6 Similarly, when a patient leaves the hospital, the pharmacist overseeing the patient's medications in 
the home setting, normally the community pharmacist, should be informed of any changes in therapy, such as new drugs, altered 
doses or discontinued medications, in order to ensure continuity of care during this transition. 3 
Impact on Patients 
Although all patients can benefit from PCMHs, certain patients are specifically targeted as having a very high potential for positive 
health impacts. The characteristics of patients that can benefit the most from PCMHs are those with a high quantity of medica-
tions, numerous chronic disease states, complicated medication regimens, poor adherence, medications with an elevated risk for 
adverse effects, physiologic states that are compromised such as renal function, poor therapeutic response to a medication regi-
men, more than one pharmacy or doctor, regular transitions of care and high health care spending (including emergency depart-
ment visits and hospital admissions).3 It is estimated that 90 million people in the United States suffer from chronic disease condi-
tions.7 Patients with a strict budget can also benefit from MTM services provided by pharmacists; it is estimated that 58 percent of 
doctors claimed that their patients struggle to afford their medications. 6 Additional roles of pharmacists in helping to reduce the 
cost of medication for patients involve incorporating evidence-based medicine and guidelines from pharmacy and therapeutic 
committees.7 Pharmacists can have a vital role with therapeutic interchange, in which a drug that is originally prescribed is re-
placed with a therapeutic equivalent with the approval of the prescriber. 7 Similarly, a clinical pharmacist can provide a training ses-
sion with newly hired physicians regarding a prescription to OTC conversion list, a drug formulary list, antibiotic appropriateness 
sheets and charts comparing the costs of medications. 7 As a result, patients will have more outpatient therapy rather than in pa-
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tient stays in hospitals due to medical emergencies, especially those which could have been prevented with a guided treatment 
approach. 2 
Another large element of the pending success of PCMHs 
centers around patient engagement and patients taking 
more responsibility for achieving their health goals. A 
medication action plan (MAP) provides an opportunity for 
patients to be involved in their medication management, 
empowering them to discuss and set reasonable personal 
goals with their pharmacist. 3 This procedure allows pa-
tients to develop a higher level of understanding of their 
medications, as well as have a plan to which they are more 
likely to adhere. By encouraging patients to take an active 
role in their health, the number of hospital and emergency 
By encouraging patients to take an active 
role in their health, the number of hospital 
and emergency department visits can be 
drastically decreased which in the long 
run saves money and resources. 
department visits can be drastically decreased which in the long run saves money and resources. 2 
Communication: A Vital Component of PCMHs 
Also, the development of electronic health records (EH Rs) and health information exchanges (HIE) are vital for meeting the connec-
tion and cooperation of health care professionals in a PCMH. 3 A central medication profile is essential for patient safety and opti-
mal outcomes, especially since many patients have multiple prescribers and pharmacies. 3 Additionally, not all medications are re-
corded on prescription claim databases since many drugs are not purchased through insurance due to low generic prices. 3 Since 
allergy and drug interactions may not be available or consistent among the information provided by patients to all health care pro-
fessionals, the HIEs can be vital.4 In situations like these, a HIE can allow for a comprehensive medication list to be available to all 
health care professionals in a secure manner, with patient approval. 3 By operating within the PCMH, pharmacists can analyze both 
a patient's drug history with diagnoses and test results, which can allow for drug therapy problems to be identified. 3 This sort of 
record keeping also aids in the patient's continuity of care. 3 
The grave importance of PCMHs is demonstrated in situations involving a transition in care. It is estimated that 23 percent of pa-
tients that are discharged from the hospital have an adverse event, mostly medication related, within 30 days from their dis-
charge.3 As a result, approximately 20 percent of these adverse effects result in a trip to the emergency department or a hospital 
readmission.3 This is often a result of a deficient amount of communication among hospitals, primary care physicians and patients. 3 
One potential solution to this currently poor model for transition of care after a hospital discharge can be improved electronic da-
tabases, as described above, which can help with medication reconciliation being relayed to the outpatient setting. 8 
Specialized Requirements and Training 
In order to work within a PCMH, there are certain qualifications that are recommended for a pharmacist. The root of the current 
roles of pharmacists began in 1990, with the introduction of the term "pharmaceutical care," which changed the role of a pharma-
cist from only filling and dispensing prescriptions to more patient-centered services, such as MTM.6 The recommended knowledge 
for a pharmacist in the PCMH set consists of "evidence-based pharmacotherapy knowledge base; direct patient care experience; 
excellent written and oral communication skills; MTM training; pharmacy specialty board certifications; residency training in ambu-
latory care, primary care, or family medicine practice settings; and a basic understanding of continuous quality improvement princi-
ples and health information technology (HIT) applications." 3 
I Employment Models There are multiple employment models for pharmacists in PCMHs. First, there is the employed model in which a pharmacist works in a 
clinical setting within the PCMH. 3 Next, there is the embedded model 
which is based on the pharmacist working in a "partnership" within a 
hospital pharmacy or pharmacy school. 3 The model has been demon-
strated to be successful in the Iowa Family Medicine Program, in 
which clinical pharmacists were employed at six community family 
residencies based on funding from a college of pharmacy and resi-
dency programs. 6 The primary goal was to improve blood pressure. 6 
The patients were split into two groups, a control group and an inter-
vention group, in which the clinical pharmacist was involved in the 
patients' therapies. Based on the role of the pharmacist, the blood 
pressure was controlled in more patients (63.9 percent) than the 
control group (29.9 percent).6 Demonstrating the significance of this 
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data, the average blood pressure decreased 20.7 /9.7 mmHg in the intervention group compared to 6.8/4.5 mmHg for the control 
group.6 There is also the regional model, in which a pharmacist works out of a health system office which operates for multiple 
PCMHs within a certain region.3 Oftentimes, the pharmacist uses a population approach to create medication management pro-
grams, in addition to providing "education programs, evaluation services and outcomes research." A pharmacist can also work 
within a contracted model for a PCMH where he would meet with patients in a variety of ways, including going to the patient's 
home, meeting the patient at the physician's office or community pharmacy, or in some cases on the telephone. 3 These are just a 
few examples of the types of employment for pharmacists within PCMHs. 
Despite the numerous advances in the organization of PCMHs, one area of PCMHs that still needs to be ironed out is how to rei m-
burse pharmacists for their services. One option is a fee-for-service model of reimbursement.3 The Asheville Project, which started 
in Asheville, North Carolina, in 1997, demonstrated the impact of pharmacists in a fee-for-service reimbursement plan. 6 Pharma-
cists were able to develop treatment goals and monitor for 
adverse reactions and patient adherence. There was a signifi-
cantly larger number of patients with diabetes (24.3 percent) 
that lowered their hemoglobin AlC levels to below 7 percent, 
when a pharmacist was involved in their treatment regimen. 6 
Overall, the return on investment for the Asheville diabetes 
program was 4:1, indicating the major impact on the health 
care system. 6 Alternately, the care coordination fee method of 
reimbursement is a method of monthly payment based on the 
number of patients in the practice. 3 Other reimbursement 
methods incorporate performance and incentives, which 
means that payment is based on lowering the number of 
preventable emergency department visits, unnecessary 
appointments with specialty physicians and the number of hos-
pitalizations.3 However, it is imperative for pharmacists and 
pharmacy organizations to advocate for the essential role of 
the pharmacist in PCMHs on the local, state and national level. 4 
Barriers 
Patient-centered medical homes have come a long way in a short time, but there are still a number of barriers that need to be 
overcome in order for them to operate efficiently and effectively. All health care professionals have to work together, oftentimes 
overlapping in patient coverage.4 Similarly, several health care professionals disagree on which components are necessities when it 
comes to a functional, effective PCMH. The major concern is the capacity of small practices to implement a PCMH. It is important 
to consider that independently owned practices with less than or equal to five physicians provide nearly 75 percent of all am bula-
tory care visits! 1 Additionally, the vast majority of community pharmacies do not have access to full patient information, but in-
stead have to call or fax a physician's office with questions about adverse reactions or drug-drug interactions.6 
PCMHs in the Clinical Setting 
Currently, there are multiple forms of PCMHs that have been established. Starting a PCMH could come about via different avenues: 
one option is to start a "medical home" for employees and then expand the program. Similarly, a hospital or health system can 
begin by focusing its attention on patients that come to the emergency department for primary care, especially those patients that 
are uninsured and/or underinsured. Another reason for starting a PCMH could be the need to develop a strategy to cope with the 
hard economic times. For example, a PCMH was created by Ellis Medicine in Schenectady, New York, after two other local hospitals 
were forced to close. As a result, Ellis Medicine became the only provider of health care services for the surrounding area of 
Schenectady, which consists of 62,000 people, of which 19.8 percent are considered to be below the poverty rate. 2 Ellis Medicine 
had to shift its targets from length of stay toward a more public health oriented style, including objectives such as the prevention 
of diabetes and obesity. Additionally, Ellis Medicine collaborated to bring various aspects of health care to its location, including a 
family practice clinic, a dental clinic, a pediatric practice, adolescent behavioral health services, a Medicaid enrollment facilitator 
and an immunization site. This system was developed to prevent, or at least decrease, the number of patients arriving at the emer-
gency department in a medical crisis. Therefore, less hospital stays will ensue, which is necessary, especially since Ellis Medicine is 
the only hospital still operating in that area. 2 
Additionally, a PCMH in Seattle, known as Group Health Cooperative, was founded on the concern that physicians were being 
forced to meet with their patients within a very confined ten to fifteen minute window. It was realized that as the productivity of 
physicians was severely compromised due to time constraints, there was a direct relationship to the management of patient 
health.2 As a result, the Group Health Cooperative began a pilot project involving a primary care team consisting of physicians, 
nurses, pharmacists and a frontline staft.2 Through this program, doctors meet with a smaller number of patients, but for a longer 
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period of time of about 30 minutes. 2 Doctors are additionally 
given the time to email or call patients, while also communicating 
on a regular basis with pharmacists and nurses to develop patient 
care plans. Based on the work of implementing the PCMH, emer-
gency department visits decreased by 29 percent and hospital 
days were reduced by 19 percent. 2 
Conclusion 
... emergency department visits 
decreased by 29 percent and hospital 
days were reduced by 19 percent. 
The evolution of health care through the ages has often been met with opposition and obstacles, but nonetheless, progress takes 
place when changes are worth the fight. While the concept of PCMHs is only in its infancy in terms of where this idea can develop, 
its fundamentals have the potential to improve health care practice and ultimately the health of patients nationwide. There are 
many flaws that exist in the health care system today; however, progression of PCMHs from its current position has the potential 
to revolutionize both pharmacy and health care as a whole. This is consistent with the views of American Academy of Pediatrics, 
American Academy of Family Practice, American College of Physicians and the American Osteopathic Association as evidenced by 
the joint published statement that they support "accessible, continuous, team-based care that focuses on the whole person, with 
the PCMH taking responsibility for care coordination." 1 Currently, PCMHs are on the horizon of health care and whether or not 
they live up to their potential is up to current and future health care professionals, including pharmacists, to both fight for and ex-
pand upon the current PCMH format! 
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